Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
2007 1
2011 1
2015 1
2016 1
2019 2
2020 3
2021 3
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Results by year
Filters applied: . Clear all
Page 1
The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancer.
Hickey TE, Selth LA, Chia KM, Laven-Law G, Milioli HH, Roden D, Jindal S, Hui M, Finlay-Schultz J, Ebrahimie E, Birrell SN, Stelloo S, Iggo R, Alexandrou S, Caldon CE, Abdel-Fatah TM, Ellis IO, Zwart W, Palmieri C, Sartorius CA, Swarbrick A, Lim E, Carroll JS, Tilley WD. Hickey TE, et al. Among authors: alexandrou s. Nat Med. 2021 Feb;27(2):310-320. doi: 10.1038/s41591-020-01168-7. Epub 2021 Jan 18. Nat Med. 2021. PMID: 33462444
Cyclin E2 Promotes Whole Genome Doubling in Breast Cancer.
Lee C, Fernandez KJ, Alexandrou S, Sergio CM, Deng N, Rogers S, Burgess A, Caldon CE. Lee C, et al. Among authors: alexandrou s. Cancers (Basel). 2020 Aug 13;12(8):2268. doi: 10.3390/cancers12082268. Cancers (Basel). 2020. PMID: 32823571 Free PMC article.
miR-99b-5p, miR-380-3p and miR-485-3p are novel chemosensitising miRNAs in high-risk neuroblastoma.
Holliday H, Yang J, Dodson E, Nikolic I, Kamili A, Wheatley M, Deng N, Alexandrou S, Davis TP, Kavallaris M, Caldon CE, McCarroll J, De Preter K, Mestdagh P, Marshall GM, Simpson KJ, Fletcher J, Swarbrick A. Holliday H, et al. Among authors: alexandrou s. Mol Ther. 2022 Jan 5:S1525-0016(22)00004-1. doi: 10.1016/j.ymthe.2022.01.004. Online ahead of print. Mol Ther. 2022. PMID: 34998954
MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer.
Portman N, Milioli HH, Alexandrou S, Coulson R, Yong A, Fernandez KJ, Chia KM, Halilovic E, Segara D, Parker A, Haupt S, Haupt Y, Tilley WD, Swarbrick A, Caldon CE, Lim E. Portman N, et al. Among authors: alexandrou s. Breast Cancer Res. 2020 Aug 12;22(1):87. doi: 10.1186/s13058-020-01318-2. Breast Cancer Res. 2020. PMID: 32787886 Free PMC article.
Ultrafast, all-silicon light modulator.
Wang CC, Currie M, Alexandrou S, Hsiang TY. Wang CC, et al. Among authors: alexandrou s. Opt Lett. 1994 Sep 15;19(18):1453-5. doi: 10.1364/ol.19.001453. Opt Lett. 1994. PMID: 19855550
Synergistic targeting of BRCA1 mutated breast cancers with PARP and CDK2 inhibition.
Aziz D, Portman N, Fernandez KJ, Lee C, Alexandrou S, Llop-Guevara A, Phan Z, Yong A, Wilkinson A, Sergio CM, Ferraro D, Etemadmoghadam D, Bowtell DD; kConFab Investigators, Serra V, Waring P, Lim E, Caldon CE. Aziz D, et al. Among authors: alexandrou s. NPJ Breast Cancer. 2021 Aug 31;7(1):111. doi: 10.1038/s41523-021-00312-x. NPJ Breast Cancer. 2021. PMID: 34465787 Free PMC article.
A Retrospective Quality Improvement Study to Describe Operational Management Strategies in an Inpatient Rehabilitation Facility During the COVID-19 Pandemic.
Struble-Fitzsimmons D, Feld-Glazman R, Dominick E, Alexandrou S, Rider E, Bogosian C, Norton J, Pacheco L, Andreassi E. Struble-Fitzsimmons D, et al. Among authors: alexandrou s. Arch Phys Med Rehabil. 2021 Dec;102(12):2482-2488. doi: 10.1016/j.apmr.2021.07.004. Epub 2021 Jul 23. Arch Phys Med Rehabil. 2021. PMID: 34303668 Free PMC article.
13 results